Faculty: Biography

Mandi Murph, Ph.D.
Associate Professor
Pharmaceutical and Biomedical Sciences
Address: Pharmacy South Building
University of Georgia
Athens, GA 30602
Office: Room 334
Phone: (706) 583-0216
Email: mmurph@uga.edu
B.S. BiologyEmory UniversityAtlanta, GA1999
Ph.D. BiologyGeorgia Institute of TechnologyAtlanta, GA2005
Post-doctoral Experience
Postdoctoral Fellow, M.D. Anderson Cancer Center, Houston, TX, 2005–2008
Honors and Awards
Suddath Award winner for pre-doctoral scientific achievement in Science and Engineering at Georgia Tech (2003)
Research Interests
Research interests in the laboratory include understanding the molecular biology of lysophosphatidic acid (LPA) signaling and the molecular mechanisms of drugs targeting this pathway. Various inhibitory compounds are at multiple stages of development in both academia and industry to target aberrant LPA signaling in disease. Those entering pre-clinical and clinical trials need to have a full investigation of molecular targets to predict off-target side effects of the drugs to ensure safety and FDA approval. In addition, selecting appropriate patients for clinical trial enrollment is crucial to the success of these compounds as drugs such as Tratuzumab owe their successful approval to a careful selection process. It is the long-term goal of the laboratory to contribute to the safe development of LPA signaling inhibitors that will provide much needed therapeutics to patients.
Representative Publications
Liu S., Murph M., Panupinthu N. and Mills, G.B. (2009) ATX-LPA receptor axis in inflammation and cancer. Cell Cycle. Nov 15;8(22):3695-701. PMID: 19855166

Liu S., Umezu-Goto M., Murph M., Lu Y., Liu W., Zhang F., Yu S., Stephens L.C., Cui X., Murrow G., Coombes K., Muller W., Hung M.C., Perou C.M., Lee A.V., Fang X., Mills G.B. (2009) Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. Jun 2;15(6):539-50. PMID: 19477432

Murph M.M., Liu W., Yu S., Lu Y., Hall H., Hennessy B.T., Lahad J., Schaner M., Helland A., Kristensen G., Børresen-Dale A.L. and Mills G.B. (2009) Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis. PLoS ONE. 4(5):e5583. PMID: 19440550

Murph M.M., Smith, D.L., Hennessy, B., Lu, Y., Joy, C., Coombes, K.R., Mills, G.B. (2008) Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting the PI3K Pathway for Specific Patients. Adv Exp Med Biol;622:183-95. PMID: 18546628

Hennessy, B.T., Murph, M., Nanjundan, M., Auersperg, N., Almeida, J., Coombes, K., Liu, J., Lu, Y., Gray, J.W., Mills, G.B. (2008) Ovarian cancer: linking genomics to new targeted discovery and molecular markers – the way ahead. Adv Exp Med Biol;617:23-40. PMID: 18497028
[back to top]